About
Single cell genomics-based drug discovery
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
79
By Phase
PHASE1: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06312423Collaborator
Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer
PHASE1Recruiting
12 participants
Started: Feb 23, 2024 · Completed: Dec 30, 2024
NCT05565417Lead Sponsor
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2Active, not recruiting
67 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2026
Funding History (1)
D
Aug 24, 2021
Locations (1)
Headquarters
Waltham, MA, United States
Map
Loading map...